Prevention of hyperacute rejection by phosphatidylinositol-anchored factor I

By Yoshitatsu M.   Miyagawa S.   Murase A.   Matsunami K.   Yamada M.   Sawa Y.   Ohtake S.   Matsuda H.   Shirakura R.  

Transplantation Proceedings, Vol. 32, Iss. 5, 2000-08 ,pp. : 905-906

Elsevier

Access to resources Recommend Favorite

Transplanted hepatocytes infected with a complement receptor type 1 (CR1)-containing recombinant adenovirus are resistant to hyperacute rejection

By Hammel J.M.   Elfeki S.K.   Kobayashi N.   Ito M.   Cai J.   Fearon D.T.   Graham F.L.   Fox I.J.  

Transplantation Proceedings, Vol. 31, Iss. 1, 1999-02 ,pp. : 939-939

Elsevier

Access to resources Recommend Favorite

Soluble Complement Receptor Type 1 and Antithrombin-III Combination Therapy Prolongs Xenograft Survival: The Role of Thrombin and Prostacyclin in Hyperacute Rejection

By Fujiwara I.   Nakajima H.   Akioka K.   Matsuda T.   Oka T.  

Transplantation Proceedings, Vol. 29, Iss. 1, 1997-02 ,pp. : 935-937

Elsevier

Access to resources Recommend Favorite

Modulation of fluid-phase complement activation inhibits hyperacute rejection in a porcine-to-human xenograft model

By Fiane A.E.   Videm V.   Lambris J.D.   Geiran O.R.   Svennevig J.L.   Mollnes T.E.  

Transplantation Proceedings, Vol. 32, Iss. 5, 2000-08 ,pp. : 899-900

Elsevier

Access to resources Recommend Favorite

Early cellular rejection of pig kidney perfused with manipulated human blood to avoid hyperacute rejection1

By Vega A.   Ramos A.   Val F.   Lopez-Hoyos M.   Ruiz J.C.   de Francisco A.L.M.   Castillo J.   Fleitas M.G.   Arias M.  

Transplantation Proceedings, Vol. 31, Iss. 6, 1999-09 ,pp. : 2643-2644

Elsevier

Access to resources Recommend Favorite